實現生命科學公司
US ˙ NasdaqCM ˙ US0044685008

簡介

本頁面提供了有關 Scott Daniel Cormack 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Scott Daniel Cormack已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:ACHV / Achieve Life Sciences, Inc. Director 22,000
如何解讀這些圖表

以下圖表顯示了在Scott Daniel Cormack進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

ACHV / Achieve Life Sciences, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ACHV / Achieve Life Sciences, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACHV / Achieve Life Sciences, Inc. Insider Trades
ACHV / Achieve Life Sciences, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ACHV / Achieve Life Sciences, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2016-06-13 OGXI Cormack Scott Daniel 4,856 1.0254 355 14.0138 4,979 730 139 44,366 891.06
2016-03-15 OGXI Cormack Scott Daniel 12,033 0.8300 880 11.3433 9,987
2015-06-12 OGXI Cormack Scott Daniel 4,571 2.6900 334 36.7633 12,296
2015-05-20 OGXI Cormack Scott Daniel 7,543 1.8800 552 25.6933 14,181
2014-08-13 OGXI Cormack Scott Daniel 18,341 3.1700 1,342 43.3233 58,141
2014-03-17 OGXI Cormack Scott Daniel 4,634 12.2500 339 167.4167 56,766
2013-08-19 OGXI Cormack Scott Daniel 3,112 8.6800 228 118.6267 27,012
2013-03-12 OGXI Cormack Scott Daniel 2,134 11.9000 156 162.6333 25,395

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACHV / Achieve Life Sciences, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Scott Daniel Cormack 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2020-05-14 2020-05-12 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Stock Option (right to buy) 		A - Award 22,000 22,000
2019-05-15 2019-05-14 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Stock Option (right to buy) 		A - Award 7,000 7,000
2018-09-21 2018-09-20 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Stock Option (right to buy) 		A - Award 12,000 12,000
2017-09-12 2017-09-08 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Common Stock 		F - Taxes -1,491 14,810 -9.15 3.09 -4,607 45,763
2017-09-12 2017-08-01 4/A ACHV ACHIEVE LIFE SCIENCES, INC.
Stock Option (right to buy) 		A - Award 11,000 11,000
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Stock Option (right to buy) 		A - Award 11,000 11,000
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Restricted Stock Unit (RSU) 		M - Exercise -454 0 -100.00
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Restricted Stock Unit (RSU) 		M - Exercise -852 0 -100.00
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Restricted Stock Unit (RSU) 		M - Exercise -852 0 -100.00
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Restricted Stock Unit (RSU) 		M - Exercise -284 0 -100.00
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Restricted Stock Unit (RSU) 		M - Exercise -1,705 0 -100.00
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Restricted Stock Unit (RSU) 		M - Exercise -568 0 -100.00
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Common Stock 		M - Exercise 1,590 9,685 19.64
2017-08-03 2017-08-01 4 ACHV ACHIEVE LIFE SCIENCES, INC.
Common Stock 		M - Exercise 3,125 16,302 23.72
2017-06-14 2017-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -5,000 5,000 -50.00
2017-06-14 2017-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -9,375 9,375 -50.00
2017-06-14 2017-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,000 89,055 5.95
2017-06-14 2017-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -4,472 144,953 -2.99 0.36 -1,610 52,183
2017-06-14 2017-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 9,375 149,425 6.69
2017-01-12 2017-10-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,687 9,375 -33.33
2017-01-12 2017-10-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -3,125 3,125 -50.00
2017-01-12 2017-01-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit 		M - Exercise -2,500 0 -100.00
2017-01-12 2017-01-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -9,375 18,750 -33.33
2017-01-12 2017-01-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -6,250 6,250 -50.00
2017-01-12 2017-01-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,687 0 -100.00
2017-01-12 2017-01-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,312 84,055 13.98
2017-01-12 2017-01-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -9,690 140,050 -6.47 0.63 -6,105 88,232
2017-01-12 2017-01-10 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 20,312 149,740 15.69
2016-06-15 2016-06-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit 		M - Exercise -5,000 10,000 -33.33
2016-06-15 2016-06-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -9,375 18,750 -33.33
2016-06-15 2016-06-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,000 73,743 7.27
2016-06-15 2016-06-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -4,856 129,428 -3.62 1.03 -4,979 132,715
2016-06-15 2016-06-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 9,375 134,284 7.51
2016-03-16 2016-03-15 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -12,033 124,909 -8.79 0.83 -9,987 103,674
2016-03-16 2016-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option (right to buy) 		A - Award 135,000 135,000
2016-03-16 2016-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option (right to buy) 		A - Award 300,000 300,000
2016-03-16 2016-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -9,375 28,125 -25.00
2016-03-16 2016-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -6,250 12,500 -33.33
2016-03-16 2016-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,688 4,687 -50.01
2016-03-16 2016-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,687 0 -100.00
2016-03-16 2016-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 25,000 136,942 22.33
2015-06-16 2015-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -9,375 28,125 -25.00
2015-06-16 2015-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -4,571 111,942 -3.92 2.69 -12,296 301,124
2015-06-16 2015-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 9,375 116,513 8.75
2015-05-21 2015-05-20 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -7,543 107,138 -6.58 1.88 -14,181 201,419
2015-05-21 2015-05-19 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		A - Award 37,500 37,500
2015-05-21 2015-05-19 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option (right to buy) 		A - Award 75,000 75,000
2015-05-21 2015-05-19 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -6,250 18,750 -25.00
2015-05-21 2015-05-19 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,687 9,375 -33.33
2015-05-21 2015-05-19 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,687 9,375 -33.33
2015-05-21 2015-05-19 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 15,624 114,681 15.77
2015-01-30 2015-01-30 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -9,206 99,057 -8.50 2.11 -19,425 209,010
2015-01-30 2015-01-27 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -20,100 0 -100.00
2015-01-30 2015-01-27 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 20,100 108,263 22.80
2014-09-19 2014-09-19 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -3,401 88,163 -3.71 3.06 -10,407 269,779
2014-09-19 2014-09-17 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -7,425 20,100 -26.98
2014-09-19 2014-09-17 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 7,425 91,564 8.82
2014-08-14 2014-08-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -18,341 84,139 -17.90 3.17 -58,141 266,721
2014-08-14 2014-08-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -37,500 0 -100.00
2014-08-14 2014-08-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 37,500 102,480 57.71
2014-06-16 2014-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		A - Award 37,500 37,500
2014-06-16 2014-06-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		A - Award 37,500 37,500
2014-03-18 2014-03-17 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -4,634 64,980 -6.66 12.25 -56,766 796,005
2014-03-18 2014-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		A - Award 40,000 40,000
2014-03-18 2014-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		A - Award 25,000 25,000
2014-03-18 2014-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option (right to buy) 		A - Award 50,000 50,000
2014-03-18 2014-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,688 14,062 -25.00
2014-03-18 2014-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,688 14,062 -25.00
2014-03-18 2014-03-14 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 9,376 69,614 15.56
2013-10-07 2013-08-19 4/A OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -3,112 60,238 -4.91 8.68 -27,012 522,866
2013-10-07 2013-03-12 4/A OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		S - Sale -2,134 56,788 -3.62 11.90 -25,395 675,777
2013-08-15 2013-08-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -6,562 16,250 -28.77
2013-08-15 2013-08-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -2,951 60,399 -4.66
2013-08-15 2013-08-13 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 6,562 63,350 11.56
2013-03-14 2013-03-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		A - Award 30,000 30,000
2013-03-14 2013-03-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		A - Award 18,750 18,750
2013-03-14 2013-03-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option (right to buy) 		A - Award 37,500 37,500
2013-03-14 2013-03-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Unit (RSU) 		M - Exercise -4,688 14,062 -25.00
2013-03-14 2013-03-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -2,134 56,788 -3.62
2013-03-14 2013-03-12 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 4,688 58,922 8.64
2012-08-07 2012-08-07 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option 		M - Exercise -7,000 0 -100.00
2012-08-07 2012-08-07 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 7,000 54,234 14.82 4.11 28,736 222,636
2012-08-01 2012-07-30 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option 		M - Exercise -34,167 7,000 -83.00
2012-08-01 2012-07-30 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 34,167 47,234 261.48 4.11 140,259 193,900
2012-05-10 2012-05-08 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 25,000 25,000
2012-05-10 2012-05-08 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 18,750 18,750
2012-05-10 2012-05-08 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Stock Option (right to buy) 		A - Award 37,500 37,500
2008-12-29 2008-12-23 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy) 		M - Exercise -24,809 0 -100.00
2008-12-29 2008-12-23 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		G - Gift 24,809 24,809
2008-12-29 2008-12-23 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		G - Gift -24,809 6,306 -79.73
2008-12-29 2008-12-23 4 OGXI ONCOGENEX PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 24,809 31,115 393.42 3.89 96,544 121,084
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）